{"cdcTestId":"2013-0270","testcaseName":"# 2 Pediarix at 10 wks-4 days","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-08-14T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-14T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2023-01-29T00:00:00","recommendedDate":"2023-02-14T00:00:00","pastDueDate":"2024-04-10T00:00:00"},"doses":[{"dateAdministered":"2022-09-14T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-02-13T08:42:28.616","generalDescription":"This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks - 4 days, that the dose is considered to be valid. ","changedInVersion":"1.0","reasonForChange":""}